This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: The Innovative Journey of Brijesh Dinkarrai Desai
Introduction
Brijesh Dinkarrai Desai, a dedicated inventor based in Gujarat, India, has made significant contributions to the field of pharmaceuticals. With one notable patent to his name, he exemplifies the spirit of innovation aimed at improving health solutions.
Latest Patents
Desai holds a patent for a groundbreaking process for the preparation of Fulvestrant, a critical medication used in the treatment of certain types of breast cancer. This patent not only includes an improved process for synthesizing Fulvestrant but also introduces a novel intermediate, enhancing the overall production methods within the pharmaceutical industry.
Career Highlights
Brijesh Desai works at Intas Pharmaceuticals Limited, a renowned company in the pharmaceutical sector. His role involves extensive research and development, focusing on creating effective solutions to combat health challenges. Desai's innovative approach has positioned him as a vital asset to the company's ongoing projects.
Collaborations
Throughout his career, Desai has collaborated with esteemed colleagues such as Mettilda Lourdusamy and Ioan Iosif Radu. These partnerships have fostered a shared pursuit of innovation and excellence, driving advancements in pharmaceutical processes and product development.
Conclusion
Brijesh Dinkarrai Desai's commitment to innovation in the pharmaceutical field highlights the importance of research and development in enhancing healthcare solutions. His contributions not only benefit the industry but also positively impact patients' lives through improved medications. As he continues his journey, the future holds promising potential for further advancements in pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile